We’re two episodes into our latest podcast series, Designing Through Disruption: Medical Innovation Under Pressure, where we explore how MIDI’s proven strategies, shaped during the COVID era, are helping MedTech teams build stronger, more resilient development pipelines in the face of today’s global supply chain challenges and tariffs.
Episode 1: The Value of Concurrent Engineering and DFX
MIDI CEO Christopher Montalbano discusses the value of embedding Concurrent Engineering and DFX early in development, especially under ISO 13485. You’ll hear how these practices, once a lifeline during the pandemic, are now helping medical device companies stay agile and compliant in today’s volatile landscape.
Episode 2: Preemptive DFX Practices in MedDevice Development
Chris takes a deeper look at Design for Excellent (DFX) strategies implemented early in the development cycle. These methods, initially honed during the COVID-19 supply chain crisis, are now proving indespensable as global tariffs and component shortages continue to challenge the industry.
👉 Catch up on the series here: Listen Now
Episode 3 is coming soon, where we’ll dive into the MedDevice Supply Chain Paradigm Shift; Defining & Solving for Supply Chain Risk Utilizing MIDI’s De-Risk Method of DFSC (Design for Supply Chain), MIDI will share unique and critical knowledge with the medical development community to assist with the augmentation and derisking of electronic design.
MIDI will be attending ADLM 2025, the premier global event for laboratory medicine, diagnostics, and clinical innovation, held July 27–31 in Chicago.
With 900+ exhibitors, 200+ scientific sessions, and thousands of attendees from across healthcare and life sciences, ADLM is the place to discover the future of diagnostics.
Why MIDI is attending:
As a medical product development firm specializing in diagnostics, design, usability, engineering, commercialization and system-level integration, MIDI helps companies bring high-performance diagnostic devices to market faster, smarter, and fully aligned with regulatory and clinical needs. Our proven process bridges user requirements, regulatory pathways, and real-world engineering to ensure commercial and clinical success.
If you’re exploring:
Let’s talk. We’re available for one-on-one meetings throughout the conference.
Click here to schedule a time with MIDI’s COO Gregory Montalbano: gregm@midipd.com
Looking forward to connecting in Chicago!
We do not share your information with third parties
